Biological activity of ruthenium and osmium arene complexes with modified paullones in human cancer cells.
about
In vitro and in vivo evaluation of water-soluble iminophosphorane ruthenium(II) compounds. A potential chemotherapeutic agent for triple negative breast cancerStriking difference in antiproliferative activity of ruthenium- and osmium-nitrosyl complexes with azole heterocyclesEffect of the piperazine unit and metal-binding site position on the solubility and anti-proliferative activity of ruthenium(II)- and osmium(II)- arene complexes of isomeric indolo[3,2-c]quinoline-piperazine hybrids.Metal-Arene Complexes with Indolo[3,2-c]-quinolines: Effects of Ruthenium vs Osmium and Modifications of the Lactam Unit on Intermolecular Interactions, Anticancer Activity, Cell Cycle, and Cellular Accumulation.A novel Osmium-based compound targets the mitochondria and triggers ROS-dependent apoptosis in colon carcinomaMetallomics insights into the programmed cell death induced by metal-based anticancer compounds.A highly cytotoxic modified paullone ligand bearing a TEMPO free-radical unit and its copper(II) complex as potential hR2 RNR inhibitors.Lipid-based carriers for controlled delivery of nitric oxide.The development of anticancer ruthenium(ii) complexes: from single molecule compounds to nanomaterials.Antimalarial activity of ruthenium(II) and osmium(II) arene complexes with mono- and bidentate chloroquine analogue ligands.Transition metal complexes with bioactive ligands: mechanisms for selective ligand release and applications for drug delivery.Novel Indole-fused benzo-oxazepines (IFBOs) inhibit invasion of hepatocellular carcinoma by targeting IL-6 mediated JAK2/STAT3 oncogenic signals.Metal Compounds as Kinase and Phosphatase Inhibitors in Drug Development: The Role of the Metal and LigandsSynthesis of 7-alkylidene-7,12-dihydroindolo[3,2-d]benzazepine-6-(5H)-ones (7-alkylidene-paullones) by N-cyclization–oxidative Heck cascade and characterization as sirtuin modulators
P2860
Q30398565-FF73A017-8C92-4A5F-873B-0B2D033532C2Q30623124-58697CE7-FD21-4F8E-815F-688FCAF7F581Q33864513-D297FCB7-295C-4E55-84E6-46C82F69C047Q36613535-1AA4A6AA-9F92-4F34-AC3D-16E2091CB562Q36973759-79F22153-13D8-418C-8ADC-36EEE49500B1Q38199383-01AF263C-DDE9-4BAC-A683-C2A8A33AD5E7Q39094955-90A213D3-40AA-4920-84BC-1A167FCB95EFQ39100762-43E014B9-E484-4AC3-BC0C-06B7F245E83BQ39400527-E8676043-BB4B-4D58-9D15-3944311D62CCQ41916555-5D017706-8D0E-47DE-BEDA-F9B609285CA6Q50803523-E7622FAC-DDF8-406A-BCBB-ECA74F8B0AF2Q52322961-86902F87-CF8D-4B54-B2F1-10D9F2C05F10Q57693525-0ADA7CFC-F465-4164-B750-ECA4572CFFEDQ58862216-DB821CD7-1636-47C8-91AA-35F39B61CFA7
P2860
Biological activity of ruthenium and osmium arene complexes with modified paullones in human cancer cells.
description
2012 nî lūn-bûn
@nan
2012年の論文
@ja
2012年学术文章
@wuu
2012年学术文章
@zh-cn
2012年学术文章
@zh-hans
2012年学术文章
@zh-my
2012年学术文章
@zh-sg
2012年學術文章
@yue
2012年學術文章
@zh
2012年學術文章
@zh-hant
name
Biological activity of rutheni ...... ullones in human cancer cells.
@en
Biological activity of rutheni ...... ullones in human cancer cells.
@nl
type
label
Biological activity of rutheni ...... ullones in human cancer cells.
@en
Biological activity of rutheni ...... ullones in human cancer cells.
@nl
prefLabel
Biological activity of rutheni ...... ullones in human cancer cells.
@en
Biological activity of rutheni ...... ullones in human cancer cells.
@nl
P2093
P2860
P1476
Biological activity of rutheni ...... aullones in human cancer cells
@en
P2093
Caroline Bartel
Gerhard Mühlgassner
Vladimir B Arion
Wolfgang F Schmid
P2860
P304
P356
10.1016/J.JINORGBIO.2012.06.003
P577
2012-06-13T00:00:00Z